Morristown, NJ, United States of America

Brian R Boettcher

This inventor holds 12 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Novartis Ag, Irm LLC. Active years: 2003-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brian R Boettcher. Retrieved from https://idiyas.com/inventor/brian-r-boettcher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 2)

% Patents Active = 66.7

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 6.7

ph-index = 5

Forward Citations = 152(Granted Patents)

Location History:

Morristown, NJ (US) (2003)
Winchester, MA (US) (2015 - 2024)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2003-2026

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12527841 - FIBROBLAST GROWTH FACTOR-21-FC FUSION PROTEINS (2026-01-20),

2. 11944664 - Fibroblast growth factor-21-Fc fusion proteins (2024-04-02),

3. 11802152 - Methods of treating FGF21-associated disorders (2023-10-31),

4. 11236159 - Methods of treating FGF21-associated disorders (2022-02-01),

5. 11129874 - Nucleic acids encoding FGF21-Fc fusion proteins (2021-09-28),

6. 10669323 - Methods of treating metabolic disorders with dual function fibroblast growth factor 21 proteins (2020-06-02),

7. 10076554 - FGF21-FC fusion proteins for treating metabolic disorders (2018-09-18),

8. 9458214 - Dual function fibroblast growth factor 21 proteins (2016-10-04),

9. 9266935 - Methods of treating metabolic disorders with an FGF21 variant (2016-02-23),

10. 9023791 - Fibroblast growth factor 21 mutations (2015-05-05),

11. 9006400 - Fibroblast growth factor-21-Fc fusion proteins (2015-04-14),

12. 6608038 - Methods and compositions for treatment of diabetes and related conditions via gene therapy (2003-08-19),

Title: Brian R Boettcher: Innovator in Pharmaceutical Sciences

Introduction

Brian R Boettcher is a notable inventor based in Morristown, NJ (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative treatments for metabolic disorders. With a total of 12 patents to his name, Boettcher's work has had a profound impact on medical research and therapeutic applications.

Latest Patents

Among his latest patents, Boettcher has developed fusion proteins comprising polypeptide and protein variants of fibroblast growth factor 21 (FGF21). This invention focuses on improving the pharmaceutical properties of these proteins and includes methods for treating FGF21-associated disorders, particularly metabolic conditions. Additionally, he has patented monoclonal antibodies and antigen-binding fragments that target human β-klotho, along with pharmaceutical compositions and treatment methods related to these antibodies.

Career Highlights

Throughout his career, Boettcher has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Irm LLC. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in drug development.

Collaborations

Boettcher has collaborated with several professionals in his field, including Shari Lynn Caplan and Douglas S Daniels. These partnerships have facilitated the advancement of his research and the successful implementation of his inventions.

Conclusion

Brian R Boettcher is a distinguished inventor whose work in pharmaceutical sciences continues to influence the treatment of metabolic disorders. His innovative patents and collaborations highlight his commitment to advancing medical research and improving patient outcomes.

Profile summary based on public USPTO records.